Pembrolizumab-induced diabetes

被引：2

作者：

Banatwalla, Rumaisa ^{[1
]}

Kirresh, Omar Zuhair ^{[2
]}

Ahmed, Fahad Wali ^{[2
]}

机构：

[1] Kings Coll Hosp NHS Fdn Trust, Endocrinol & Diabet, London, England

[2] Univ Hosp Sussex NHS Fdn Trust, Royal Sussex Cty Hosp, Diabet & Endocrinol, Eastern Rd, Brighton BN2 5BE, E Sussex, England

来源：

ENDOKRYNOLOGIA POLSKA | 2021年 / 72卷 / 04期

关键词：

pembrolizumab; diabetes; diabetic ketoacidosis; malignant melanoma; check-point inhibitors;

D O I：

10.5603/EP.a2021.0053

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：414 / 415

页数：2

共 6 条

[1] Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports [J].

Abdel-Wahab, Noha ;

Shah, Mohsin ;

Suarez-Almazor, Maria E. .

PLOS ONE, 2016, 11 (07)

[2] Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus [J].

Clotman, Katrien ;

Janssens, Katleen ;

Specenier, Pol ;

Weets, Ilse ;

De Block, Christophe E. M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (09) :3144-3154

[3] PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction [J].

Colli, Maikel L. ;

Hill, Jessica L. E. ;

Marroqui, Laura ;

Chaffey, Jessica ;

Dos Santos, Reinaldo S. ;

Leete, Pia ;

de Brachene, Alexandra Coomans ;

Paula, Flavia M. M. ;

de Beeck, Anne Op ;

Castela, Angela ;

Marselli, Lorella ;

Krogvold, Lars ;

Dahl-Jorgensen, Knut ;

Marchetti, Piero ;

Morgan, Noel G. ;

Richardson, Sarah J. ;

Eizirik, Decio L. .

EBIOMEDICINE, 2018, 36 :367-375

[4] Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study [J].

Eshet, Yael ;

Baruch, Erez Nissim ;

Shapira-Frommer, Ronnie ;

Steinberg-Silman, Yael ;

Kuznetsov, Teodor ;

Ben-Betzalel, Guy ;

Daher, Sameh ;

Gluck, Iris ;

Asher, Nethanel ;

Apter, Sara ;

Schachter, Jacob ;

Bar, Jair ;

Boursi, Ben ;

Markel, Gal .

CANCER IMMUNOLOGY RESEARCH, 2018, 6 (12) :1453-1458

[5] Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues [J].

Ishida, M ;

Iwai, Y ;

Tanaka, Y ;

Okazaki, T ;

Freeman, GJ ;

Minato, N ;

Honjo, T .

IMMUNOLOGY LETTERS, 2002, 84 (01) :57-62

[6] Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors [J].

Stamatouli, Angeliki ;

Quandt, Zoe ;

Perdigoto, Ana Luisa ;

Clark, Pamela L. ;

Kluger, Harriet ;

Weiss, Sarah A. ;

Gettinger, Scott ;

Sznol, Mario ;

Young, Arabella ;

Rushakoff, Robert ;

Lee, James ;

Bluestone, Jeffrey A. ;

Anderson, Mark ;

Herold, Kevan C. .

DIABETES, 2018, 67 (08) :1471-1480

← 1 →